Cross-sectional HIV and HCV cascades of care across the regions of Ukraine between 2019 and 2020: findings from the CARE cohort

CONCLUSIONS: Over 98% of PLHIV in care in both CARE sites in Ukraine were receiving ART, and the target of 90% virally suppressed was achieved in persons >6 months on ART. Only one of six HIV/HCV study sites tested over 50% anti-HCV-positive PLHIV for HCV-RNA and treated over 25% of eligible persons. While free HCV-RNA testing and DAA treatment are paramount to achieving HCV elimination targets, they remained a challenge in Ukraine in 2019-2020. The extent of the HIV and HCV care disruption during the war will be further assessed in the CARE cohort and compared with the pre-war findings.PMID:37705358 | PMC:PMC10500257 | DOI:10.1002/jia2.26166

Source: Journal of the International AIDS Society - September 14, 2023 Category: Infectious Diseases Authors: Olga Fursa Joanne Reekie Ihor Kuzin Larysa Hetman Alina Kryshchuk Olena Starychenko Nana Hrytsaiuk Inna Khodus Alla Nyzhnyk Viktoriia Rakhuba Maryna Kovalevska Tetiana Maistat Iryna Pryhoda Marianna Ahieieva Olena Varvarovska Olena Valdenmaiier Jens Lundg Source Type: research